Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of a Multi-omics Platform for Hematological Malignancies
NCT07445438Recruiting
- Sponsor
- Azienda Ospedaliero-Universitaria di Parma
- Start
- Mar 2025
- Primary completion
- Mar 2030
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Azienda Ospedaliero-Universitaria di Parma. Primary endpoints: Characterization of multi-omics features to identify disease biomarkers and Evaluation of anti-cancer activity of bioactive compounds for functional pharmacotyping. Started Mar 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07445438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07445438.